Anthony L. DeVico mainly investigates Virology, Molecular biology, Virus, Immunology and Cytokine. The various areas that Anthony L. DeVico examines in his Virology study include Chemokine, Epitope, Antibody and Glycoprotein. His research integrates issues of Cytotoxic T cell, T lymphocyte and CD8 in his study of Chemokine.
His Molecular biology research is multidisciplinary, relying on both Receptor, Affinity chromatography, Gp41 and Edman degradation. His studies in Cytokine integrate themes in fields like β chemokines, Kaposi's sarcoma, Cellular immunity, Replication and Cytotoxicity. Anthony L. DeVico combines subjects such as Signal transduction, CCL5, CXCR4 and Macrophage inflammatory protein with his study of Chemokine receptor CCR5.
His primary areas of investigation include Virology, Antibody, Immunology, Chemokine and Virus. His study in Virology is interdisciplinary in nature, drawing from both Epitope, Gp41 and DNA vaccination. His Antibody study integrates concerns from other disciplines, such as Molecular biology, HIV vaccine and Biochemistry.
His studies examine the connections between Immunology and genetics, as well as such issues in Acquired immunodeficiency syndrome, with regards to Viral disease and Immunopathology. His Chemokine research includes elements of T cell, Chemotaxis and CD8. Anthony L. DeVico has researched Virus in several fields, including Cellular immunity and Cell culture.
His scientific interests lie mostly in Virology, Antibody, Antibody-dependent cell-mediated cytotoxicity, Epitope and Immunology. His research in Virology is mostly concerned with Virus. Anthony L. DeVico has included themes like Anti hiv, Affinity chromatography, Biochemistry and Antigen in his Antibody study.
His Antibody-dependent cell-mediated cytotoxicity research integrates issues from Cell-mediated cytotoxicity, Cancer research and Effector. As a member of one scientific family, Anthony L. DeVico mostly works in the field of Effector, focusing on Cytometry and, on occasion, Cytotoxic T cell. His work on Gp41 as part of general Epitope study is frequently linked to Human plasma, bridging the gap between disciplines.
His primary scientific interests are in Antibody, Virology, Epitope, Antibody-dependent cell-mediated cytotoxicity and Effector. His work deals with themes such as Isoelectric focusing, Affinity chromatography and Peptide sequence, which intersect with Antibody. His research is interdisciplinary, bridging the disciplines of Immunology and Virology.
His research investigates the link between Epitope and topics such as Specific antibody that cross with problems in Immunoglobulin G. In his study, Cytotoxic T cell is strongly linked to Monocyte, which falls under the umbrella field of Antibody-dependent cell-mediated cytotoxicity. His research in Cytotoxic T cell intersects with topics in Chemokine, Secretion and CD8.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Identification of RANTES, MIP-1α, and MIP-1β as the Major HIV-Suppressive Factors Produced by CD8+ T Cells
Fiorenza Cocchi;Anthony L. DeVico;Alfredo Garzino-Demo;Suresh K. Arya.
Immune-Correlates Analysis of an HIV-1 Vaccine Efficacy Trial
Barton F. Haynes;Peter B. Gilbert;M. Juliana McElrath;Susan Zolla-Pazner.
The New England Journal of Medicine (2012)
Characterization of highly immunogenic p66/p51 as the reverse transcriptase of HTLV-III/LAV
F. Di Marzo Veronese;T. D. Copeland;A. L. Devico;Rukhsana Rahman.
The V3 domain of the HIV–1 gp120 envelope glycoprotein is critical for chemokine–mediated blockade of infection
Florenza Cocchi;Anthony L. DeVico;Alfredo Garzino-Demo;Andrea Cara.
Nature Medicine (1996)
Characterization of gp41 as the transmembrane protein coded by the HTLV-III/LAV envelope gene.
Fulvia DiMarzo Veronese;Anthony L. DeVico;Terry D. Copeland;Stephen Oroszlan.
Antibody-Dependent Cellular Cytotoxicity-Mediating Antibodies from an HIV-1 Vaccine Efficacy Trial Target Multiple Epitopes and Preferentially Use the VH1 Gene Family
Mattia Bonsignori;Justin Pollara;M. Anthony Moody;Michael D. Alpert.
Journal of Virology (2012)
Identification of a major growth factor for AIDS-Kaposi's sarcoma cells as oncostatin M.
Bala Chandran Nair;Anthony L. DeVico;Shuji Nakamura;Terry D. Copeland.
Inhibition of HIV-1 Infection by the β-Chemokine MDC
Ranajit Pal;Alfredo Garzino-Demo;Phillip D. Markham;Jennifer Burns.
Long-term inhibition of human T-lymphotropic virus type III/lymphadenopathy-associated virus (human immunodeficiency virus) DNA synthesis and RNA expression in T cells protected by 2',3'-dideoxynucleosides in vitro
H Mitsuya;R F Jarrett;M Matsukura;F Di Marzo Veronese.
Proceedings of the National Academy of Sciences of the United States of America (1987)
Crosslinked HIV-1 envelope-CD4 receptor complexes elicit broadly cross-reactive neutralizing antibodies in rhesus macaques.
Timothy Fouts;Karla Godfrey;Kathryn Bobb;David Montefiori.
Proceedings of the National Academy of Sciences of the United States of America (2002)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: